These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 37257331)
1. The joint role of methylation and immune-related lncRNAs in ovarian cancer: Defining molecular subtypes and developing prognostic signature. Gao K; Lian W; Zhao R; Huang W; Xiong J Transl Oncol; 2023 Aug; 34():101704. PubMed ID: 37257331 [TBL] [Abstract][Full Text] [Related]
2. An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma. Shao D; Li Y; Wu J; Zhang B; Xie S; Zheng X; Jiang Z Front Genet; 2022; 13():903117. PubMed ID: 35692827 [No Abstract] [Full Text] [Related]
3. Establishment of a new molecular subtyping and prognostic signature with m6A/m5C/m1A/m7G regulatory genes for hepatocellular carcinoma. Liu T; Wang Y; Li Z; Sun L; Yang K; Chen J; Han X; Qi L; Zhou X; Wang P Heliyon; 2023 Nov; 9(11):e21285. PubMed ID: 38027812 [TBL] [Abstract][Full Text] [Related]
4. A novel m6A/m5C/m1A/m7G-related classification and risk signature predicts prognosis and reveals immunotherapy inclination in gastric cancer. Chen R; Jiang L Transl Cancer Res; 2024 Jul; 13(7):3285-3298. PubMed ID: 39145046 [TBL] [Abstract][Full Text] [Related]
5. Involvement of RNA methylation modification patterns mediated by m7G, m6A, m5C and m1A regulators in immune microenvironment regulation of Sjögren's syndrome. Liu Y; Zhu J; Ding L Cell Signal; 2023 Jun; 106():110650. PubMed ID: 36935085 [TBL] [Abstract][Full Text] [Related]
6. The prognostic value and immune landscapes of m1A/m5C/m6A-associated lncRNA signature in osteosarcoma. Wu ZY; Shi ZY Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5868-5883. PubMed ID: 36066162 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the m6A/m1A/m5C/m7G-related regulators on the prognosis and immune microenvironment of glioma by integrated analysis of scRNA-seq and bulk RNA-seq data. Yang L; Huang Z; Deng Y; Zhang X; Lv Z; Huang H; Sun Q; Liu H; Liang H; He B; Hu F J Gene Med; 2024 Feb; 26(2):e3666. PubMed ID: 38391150 [TBL] [Abstract][Full Text] [Related]
8. The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer. Cusenza VY; Tameni A; Neri A; Frazzi R Front Oncol; 2023; 13():1063636. PubMed ID: 36969033 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma. Xiao Y; Li J; Wu J BMC Med Genomics; 2023 Jul; 16(1):177. PubMed ID: 37525171 [TBL] [Abstract][Full Text] [Related]
10. Identification of RNA Methylation-Related lncRNAs Signature for Predicting Hot and Cold Tumors and Prognosis in Colon Cancer. He R; Man C; Huang J; He L; Wang X; Lang Y; Fan Y Front Genet; 2022; 13():870945. PubMed ID: 35464855 [TBL] [Abstract][Full Text] [Related]
11. Exploration and validation of a combined Hypoxia and m6A/m5C/m1A regulated gene signature for prognosis prediction of liver cancer. Ren M; Fan B; Cao G; Zong R; Feng L; Sun H BMC Genomics; 2023 Dec; 24(1):776. PubMed ID: 38097948 [TBL] [Abstract][Full Text] [Related]
12. The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma. Liu T; Sun L; Li ZZ; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P BMC Gastroenterol; 2023 May; 23(1):147. PubMed ID: 37170222 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma. Wei W; Liu C; Wang M; Jiang W; Wang C; Zhang S Front Genet; 2022; 13():906496. PubMed ID: 35938009 [TBL] [Abstract][Full Text] [Related]
14. RNA methylation-related genes of m6A, m5C, and m1A predict prognosis and immunotherapy response in cervical cancer. Wang Y; Mao Y; Wang C; Jiang X; Tang Q; Wang L; Zhu J; Zhao M Ann Med; 2023 Dec; 55(1):2190618. PubMed ID: 37042849 [TBL] [Abstract][Full Text] [Related]
15. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis. Zheng P; Li N; Zhan X Front Endocrinol (Lausanne); 2022; 13():972341. PubMed ID: 36545327 [TBL] [Abstract][Full Text] [Related]
16. Development of m6A/m5C/m1A regulated lncRNA signature for prognostic prediction, personalized immune intervention and drug selection in LUAD. Ma C; Gu Z; Yang Y J Cell Mol Med; 2024 Apr; 28(8):e18282. PubMed ID: 38647237 [TBL] [Abstract][Full Text] [Related]
17. Identification of molecular subtypes and a prognostic signature based on m6A/m5C/m1A-related genes in lung adenocarcinoma. Zhang Y; Jia Q; Li F; Luo X; Wang Z; Wang X; Wang Y; Zhang Y; Li M; Bian L Sci Rep; 2024 Mar; 14(1):7543. PubMed ID: 38555384 [TBL] [Abstract][Full Text] [Related]
18. The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma. Li R; Chen H; Li C; Qi Y; Zhao K; Wang J; You C; Huang H BMC Bioinformatics; 2023 Jul; 24(1):274. PubMed ID: 37403043 [TBL] [Abstract][Full Text] [Related]
19. Identification of m6A/m5C-related lncRNA signature for prediction of prognosis and immunotherapy efficacy in esophageal squamous cell carcinoma. Wang J; Ren H; Xu C; Yu B; Cai Y; Wang J; Ni X Sci Rep; 2024 Apr; 14(1):8238. PubMed ID: 38589454 [TBL] [Abstract][Full Text] [Related]
20. A prognostic signature based on genes associated with m6A/m5C/m1A/m7G modifications and its immunological characteristics in clear cell renal cell carcinoma. He W; Cong Z; Niu C; Cheng F; Yi T; Yao Z; Zhang Y; Jiang X; Sun X; Niu Z; Fu Q Sci Rep; 2024 Aug; 14(1):18708. PubMed ID: 39134681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]